These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 48234)

  • 1. [Is the prostatic adenoma of hormonal origin].
    Bercovici JP; Morfin R; Charles JF
    Nouv Presse Med; 1975 Feb; 4(7):475-8. PubMed ID: 48234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benign prostatic hyperplasia: etiological considerations.
    Walsh PC
    Prog Clin Biol Res; 1976; 6():1-8. PubMed ID: 66685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgens and estrogens in the plasma and prostatic tissue of normal dogs and dogs with benign prostatic hypertrophy.
    Lloyd JW; Thomas JA; Mawhinney MG
    Invest Urol; 1975 Nov; 13(3):220-22. PubMed ID: 53217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentration of dihydrotestosterone and 3 alpha-androstanediol in naturally occurring and androgen-induced prostatic hyperplasia in the dog.
    Moore RJ; Gazak JM; Quebbeman JF; Wilson JD
    J Clin Invest; 1979 Oct; 64(4):1003-10. PubMed ID: 90055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathogenesis of prostatic hyperplasia in normal and adenomatous glands of men and dogs: 3-alpha reduction of dihydrotestesterone].
    Jacob GH
    Endokrinologie; 1977 Oct; 70(2):158-68. PubMed ID: 73458
    [No Abstract]   [Full Text] [Related]  

  • 6. Dihydrotestosterone in prostatic hypertrophy. II. The formation and content of dihydrotestosterone in the hypertrophic canine prostate and the effect of dihydrotestosterone on prostate growth in the dog.
    Gloyna RE; Siiteri PK; Wilson JD
    J Clin Invest; 1970 Sep; 49(9):1746-53. PubMed ID: 4194769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone metabolism in prostate; formation of androstan-17-beta-ol-3-one and androst-4-ene-3, 17-dione, and inhibitory effect of natural and synthetic estrogens.
    Shimazaki J; Kurihara H; Ito Y; Shida K
    Gunma J Med Sci; 1965 Dec; 14(4):313-25. PubMed ID: 4162344
    [No Abstract]   [Full Text] [Related]  

  • 8. [5 alpha-dihydrotestosterone and prostatic adenoma].
    Morfin R; Charles JF; Bercovici JP
    J Urol Nephrol (Paris); 1978; 84(10-11):691-703. PubMed ID: 84877
    [No Abstract]   [Full Text] [Related]  

  • 9. Conversion of 3H-testosterone to dihydrotestosterone in human hypertrophic prostatic tissue.
    Baranowska B; Zgliczyński S
    Nuklearmedizin; 1979; 18(6):297-9. PubMed ID: 94161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen metabolism in the hypertrophic prostate.
    Wilson JD; Gloyna RE; Siiteri PK
    J Steroid Biochem; 1975; 6(3-4):443-5. PubMed ID: 52762
    [No Abstract]   [Full Text] [Related]  

  • 11. Some aspects of the pathogenesis of prostatic hyperplasia.
    Tveter KJ
    Acta Pathol Microbiol Scand Suppl; 1974; Suppl 248():167-74. PubMed ID: 4141576
    [No Abstract]   [Full Text] [Related]  

  • 12. Androgen assimilation by normal and hyperplastic dog prostate glands.
    Mawhinney MG; Schwartz FL; Thomas JA; Lloyd JW
    Invest Urol; 1974 Jul; 12(1):17-22. PubMed ID: 4135034
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of dutasteride on intraprostatic dihydrotestosterone concentrations in men with benign prostatic hyperplasia.
    Wurzel R; Ray P; Major-Walker K; Shannon J; Rittmaster R
    Prostate Cancer Prostatic Dis; 2007; 10(2):149-54. PubMed ID: 17189955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recent results of prostatic adenoma research].
    Kaufmann J
    Z Urol Nephrol; 1975 Nov; 68(11):. PubMed ID: 58501
    [No Abstract]   [Full Text] [Related]  

  • 15. [Measurement of T and DHT contents in normal and diseased human prostate tissues].
    Zhang Y; Ye L; Ding Q; Fang Z; Yao M; Shi D
    Zhonghua Wai Ke Za Zhi; 2000 Jul; 38(7):545-7. PubMed ID: 11832106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydrotestosterone in prostatic hypertrophy. I. The formation and content of dihydrotestosterone in the hypertrophic prostate of man.
    Siiteri PK; Wilson JD
    J Clin Invest; 1970 Sep; 49(9):1737-45. PubMed ID: 4194768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalent decrease of the EGF content in the periurethral zone of BPH tissue induced by treatment with finasteride or flutamide.
    Monti S; Sciarra F; Adamo MV; Toscano V; Trotta MC; Martini C; Lanzara S; Silverio FD
    J Androl; 1997; 18(5):488-94. PubMed ID: 9349746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3alpha-Reduction of dihydrotestosterone in human normal and hypertrophic prostatic tissues.
    Shida K; Shimazaki J; Ito Y; Yamanaka H; Nagai-Yuasa H
    Invest Urol; 1975 Nov; 13(3):241-5. PubMed ID: 53218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostatic growth: new insights into hormonal regulation.
    McConnell JD
    Br J Urol; 1995 Jul; 76 Suppl 1():5-10. PubMed ID: 7544215
    [No Abstract]   [Full Text] [Related]  

  • 20. Changes in dihydrotestosterone metabolism associated with the development of canine benign prostatic hyperplasia.
    Isaacs JT; Coffey DS
    Endocrinology; 1981 Feb; 108(2):445-53. PubMed ID: 6161001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.